Breaking News, Promotions & Moves

ZYUS Names Scott Livingstone Clinical Research VP

Livingstone brings extensive healthcare expertise and strategic leadership.

ZYUS Life Sciences Corp., a Canadian-based life sciences company, appointed Scott Livingstone vice president of clinical research with its wholly owned subsidiary, ZYUS Life Sciences Inc. Livingstone will lead the company’s clinical research initiatives and oversee ZYUS’ Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of Trichomylin softgel capsules in patients with advanced cancer and moderate to severe cancer-related pain. Prior to joining ZYUS, Livingstone serve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters